Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UKNOWN
UNII: 3OKH1W5LZE

Structure

InChI Key IVRXNBXKWIJUQB-UHFFFAOYSA-N
Smile Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1
InChI
InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28)

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H19N5O
Molecular Weight 369.43
AlogP 3.51
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 3.0
Polar Surface Area 86.69
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR TGF-beta receptor type I inhibitor PubMed PubMed Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Myelodysplastic Syndromes 2 D009190 ClinicalTrials
Carcinoma, Hepatocellular 2 D006528 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Nasopharyngeal Neoplasms 2 D009303 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Glioma 1 D005910 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Neoplasm Metastasis 1 D009362 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 137064
ChEMBL CHEMBL2364611
DrugBank DB11911
EPA CompTox DTXSID00220362
FDA SRS 3OKH1W5LZE
Guide to Pharmacology 7797
SureChEMBL SCHEMBL12922153
ZINC ZINC000003959536